Melanoma Open House on May 24 At Moores UC San Diego Cancer Center

 

May 07, 2007  |  

Most people living in Southern California are familiar with skin cancer, but melanoma, its most deadly form, is not as well understood.  Prevention and diagnosis of melanoma are not clear-cut and the incidence and death rates are rising. Today melanoma affects one person in 34.

If you or someone you know has questions or concerns about melanoma, please plan to attend a free Melanoma Open House sponsored by the UC San Diego Moores Cancer Center from 6:30 to 8:30 p.m. Thursday, May 24.  Melanoma experts from the Cancer Center will share the latest information on prevention, detection, and medical and surgical therapies, and will answer questions.

Guests will also have the opportunity to use the “DermaScan” skin assessment device to view sun damage to their skin, which is often invisible to the naked eye.

The event will be held in the Goldberg Auditorium at the Center, 3855 Health Sciences Dr., La Jolla. Refreshments provided. Free parking. To attend, please call 858-822-6189 with name and the number attending.

This event is made possible with support from Schering-Plough, Novartis and UC San Diego.

# # #

Media Contact: Nancy Stringer, 619-543-6163,nstringer@ucsd.edu




Media Contact

Share This Article


Related News

9/21/2017
Chronic tissue inflammation resulting from obesity is an underlying cause of insulin resistance and type 2 diabetes. But the mechanism by which this occurs has remained cloaked, until now. In a paper, ...
9/21/2017
Checkpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in a minority of patients. University of California San Diego Sch ...
9/20/2017
Researchers at University of San Diego School of Medicine have developed a new tool called the San Diego Wisdom Scale (SD-WISE) to assess an individual’s level of wisdom, based upon a conceptualizatio ...
9/19/2017
It is estimated that up to 75 percent of breast cancer survivors experience problems with cognitive difficulties following treatments, perhaps lasting years. Currently, few science-based options are a ...



Follow Us